Paredes-Aguilera R, Ortega-Aramburu JJ

Idioma: Español
Referencias bibliográficas: 20
Paginas: 113-118
Archivo PDF: 53.08 Kb.

FRAGMENTO

Con el proyecto Genoma Humano ha surgido un renovado interés en la investigación Biomédica. Hace apenas algunos años los Biólogos creían que los genes que se habían descubierto a través de mutaciones, selecciones y esquemas de clonación representaban una buena aproximación al universo total de genes, y que las proteínas ya descubiertas en base a su abundancia, localización o actividad, bien representaban el universo total de proteínas. Una de las contribuciones del proyecto Genoma Humano ha sido hacernos aparente que tan poco de ese mundo nos era realmente conocido y que tanto falta por explorar de este campo. El advenimiento de la tecnología de microarreglos de DNA, la cual proveyó una técnica útil para la comparación de los patrones globales de expresión génica entre los tejidos normales y anormales, evidentemente ha significado un avance importante en nuestra comprensión de los procesos proliferativos malignos.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Creutzig U, Zimmermann M, Ritter J, Henze G, Graf N , Schellong G . Definition of a standard-risk group in children with AML. Br J Haematol 1999;104:630-9

2. Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F et al, for the AML-BFM study group. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. J Clin Oncol 2001;19:2705-13

3. Stevens RF, Hann MI, Wheatley K, Gray RG on behalf of the MRC Childhood Leukaemia Working Party. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia : results of the United Kingdom Medical Research Council´s 10th AML trial. Br J Haemat 1998;101:130-40.

4. Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman Parker et al. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia on first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology. Bone Marrow Transplant 1996;17:191-6

5. Woods WG, Neudorf S, Gold S, Sanders J, Buckley JD, Barnard DR et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children´s Cancer Group. Blood 2001;97:56-62.

6. Gorin NC (review article). Autologous stem cell transplantation in acute myeloid leukemia. Blood 1998;92:1073-90.

7. Miller CB, Rowlings RA, Zhang MJ, Jones RJ, Piantadosi S, Keating A et al. The effect of graft purging with 4-hydroperoxyxyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. Exper. Hematology 2001; 29:1336-46

8. Sanz MA, Martin G, Rayon C, Esteve J, González M, Díaz-Mediavilla J et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR-alpha-positive acute promyelocytic leukemia. Blood 1999;94:3015-21

9. George SL, Rhomes JA, Mauer AM, Simone JV. A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med 1979;300:269-273.

10. Land VJ, Berry DH, Herson J, et al. Long –term survival in childhood acute leukemia. Med Ped Oncol 1979;7:19-24.

11. Baum E, Sather H, Nachman J, et al. Relapse rates following cessation of chemotherapy during complete remission of acute lymphocytic leukemia. Med Ped Oncol 1979;7:25-34.

12. 253 Mandelli F, Amadori S, Cantu-Rajnoldi A, et al. Discontinuing therapy in childhood acute lymphocytic leukemia. Cancer 1980;46:1319-1323.

13. Hardisty RM, Till MM, Peto J. Acute lymphoblastic leukaemia: four-year survivals old and new. J Clin Pathol 1981;34:249-

14. Conter V, Arico M, Valsecchi MG, et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982-1995. Leukemia (2000) 14;2196-2204.

15. Shrappe M, Reiter A, Zimmermann M. et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia (2000) 14;2205-2222.

16. Gaynon PS, Trigg ME, Neerema NA, et al. Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983- 1995. Leukemia (2000) 14;2223-2233.

17. Maloney KW, Shuster JJ, Murphy S, et al. Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia (2000) 14;2276-2285.

18. Pui C-H, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children’s Research Hospital. Leukemia (2000) 14;2286-2294.

19. Silverman LB, Declerck L, Gelber RD, et al. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995) Leukemia (2000);14:2247-2256.

20. Chessels J. Relapsed acute lymphoblastic leukemia: Bone marrow transplant or conventional treatment? Hematology ASH;2000:291-302.